Ember Therapeutics Inc
Ember Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company focuses on the clinical application of bone morphogenetic protein-7 (BMP-7) to develop regenerative medicines for the disease modification of osteoarthritis (OA), reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases, such as chronic kidney disease (CKD) and Alport'… Read more
Ember Therapeutics Inc (EMBT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2015: 0.024x
Based on the latest financial reports, Ember Therapeutics Inc (EMBT) has a cash flow conversion efficiency ratio of 0.024x as of September 2015.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.02K) by net assets ($-252.50K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ember Therapeutics Inc - Cash Flow Conversion Efficiency Trend (2012–2014)
This chart illustrates how Ember Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ember Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ember Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
St Elmo Silver Mines Corp
PINK:STLM
|
N/A |
|
Premier Power Renewable Energy Inc
PINK:PPRW
|
0.716x |
|
Dewmar Intl Bmc Inc
PINK:DEWM
|
-0.242x |
|
USA Recycling Industries Inc
PINK:USRI
|
-0.006x |
|
Carefree Group Inc
PINK:CRFU
|
N/A |
|
LOUD Technologies Inc
PINK:LTEC
|
-0.058x |
|
Live Microsystems Inc
PINK:LMSC
|
0.036x |
|
Williston Holding Company Inc
PINK:WHCA
|
0.333x |
Annual Cash Flow Conversion Efficiency for Ember Therapeutics Inc (2012–2014)
The table below shows the annual cash flow conversion efficiency of Ember Therapeutics Inc from 2012 to 2014.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2014-12-31 | $-238.47K | $-16.72K | 0.070x | -33.19% |
| 2013-12-31 | $-215.23K | $-22.59K | 0.105x | +334.28% |
| 2012-12-31 | $-198.90K | $-4.81K | 0.024x | -- |